The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Conflict-of-Interest Policies for Investigators in Clinical Trials
Open accessAbstract
BACKGROUND: There is substantial concern that financial conflicts of interest on the part of investigators conducting clinical trials may compromise the well-being of research subjects. METHODS: We analyzed policies governing conflicts of interest at the 10 medical schools in the United States that receive the largest amount of research funding from the National Institutes of Health. These institutions are Baylor College of Medicine, Columbia University College of Physicians and Surgeons, Harvard Medical School, Johns Hopkins University School of Medicine, the University of Pennsylvania School of Medicine, the University of California at Los Angeles School of Medicine, the University of California at San Francisco School of Medicine, the University of Washington School of Medicine, Washington University School of Medicine at St. Louis, and Yale University School of Medicine. RESULTS: All 10 universities required that faculty members disclose financial interests to university officials. Only four required disclosure by all members of the research staff. Five universities required disclosure of all financial interests, even though federal regulations specify a threshold for disclosure. Six universities required disclosure to the institutional review board as well as to a committee on conflicts of interest or a university official. Four universities had stricter requirements for investigators conducting clinical trials than required by federal regulations. One university prohibited investigators from having stock, stock options, consulting agreements, or decision-making positions involving a company that sponsored the research. A second university prohibited researchers from trading stock or stock options in a company that sponsored the research or sold the product or device under study. Two universities ordinarily did not allow faculty members to participate in clinical research if they had what federal regulations refer to as a "significant" financial interest in the company owning the product or device being studied, but exceptions were allowed. CONCLUSIONS: Policies governing conflicts of interest at leading medical schools in the United States vary widely. We suggest that university-based investigators and research staff be prohibited from holding stock, stock options, or decision-making positions in a company that may reasonably appear to be affected by the results of their clinical research. Of the 10 medical schools we studied, only 1 had a policy that was close to this standard.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uneasy alliance—clinical investigators and the pharmaceutical industry
Bodenheimer, T. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422024 · Cited by 765
Cited by
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
“A survey of 10 research-oriented medical schools reported that only 1 institution prohibited investigators from having equity, consulting agreements, or decisionmaking positions in a company sponsoring their research.(61) Another survey found that only 19% of institutions had specific limits on their faculties’ resear…”
Conflict of Interest in Medical Research, Education, and Practice
(2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 807
How to critically appraise an article
Young, J. M., & Solomon, M. J. (2009) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1331 · Cited by 178
“Researchers are in a position to decide which studies will be conducted in their unit, which patients will be invited to participate in a study and whether certain clinical occurrences should be reported as adverse events”
BackgroundReplication in prevention science
Valentine, J. C., Biglan, A., Boruch, R. F., Castro, F. G., Collins, L. M., Flay, B. R., Kellam, S., Mościcki, E. K., & Schinke, S. P. (2011) · Prevention Science · doi:10.1007/s11121-011-0217-6 · Cited by 166
The Price of Truth: How Money Affects the Norms of Science
Resnik, D. B. (2007) · doi:10.1093/acprof:oso/9780195309782.001.0001 · Cited by 160
Metadata
- Authors
- Lo, B., Wolf, L. E., & Berkeley, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-11-30
- Volume
- 343
- Issue
- 22
- Pages
- 1616-1620
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1974563874
- Cited by
- 218
- References
- 1
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Conflict-of-Interest Policies for Investigators in Clinical Trials. https://app.cochat.ai/papers/10.1056/nejm200011303432206
- The paper
- Lo, B., Wolf, L. E., & Berkeley, A. (2000). Conflict-of-Interest Policies for Investigators in Clinical Trials. New England Journal of Medicine. https://doi.org/10.1056/nejm200011303432206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.